Articles

Sort by
Previous Page Page 1 of 1 Next Page
  1. Research

    Incidence of hepatitis C among people who inject drugs in Ireland

    Comprehensive information on the incidence and duration of hepatitis C virus (HCV) infection for people who inject drugs (PWID) in Ireland is not available. We created an incidence curve of injecting drug use ...

    Anne Marie Carew, Niamh Murphy, Jean Long, Kate Hunter, Suzi Lyons, Cathal Walsh and Lelia Thornton

    Hepatology, Medicine and Policy 2017 2:7

    Published on: 26 January 2017

  2. Roundtable discussion

    Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting report

    Hepatitis B is preventable and hepatitis C is treatable even if still at a high cost; most people who are infected with hepatitis B or C virus have not been screened yet and are unaware of their infections; an...

    David FitzSimons, Greet Hendrickx, Johannes Hallauer, Heidi Larson, Daniel Lavanchy, Ina Lodewyckx, Daniel Shouval, John Ward and Pierre Van Damme

    Hepatology, Medicine and Policy 2016 1:16

    Published on: 16 December 2016

  3. Debate

    The Berlin Hepatitis C Manifesto: access to prevention, testing, treatment and care for people who use drugs

    The treatment of hepatitis C has entered a new era since the advent of curative pharmaceuticals. As policy, government and civil society assemble in response, there are still gaps to be addressed. The Manifest...

    Eberhard Schatz, Katrin Schiffer, Mags Maher, Magdalena Harris, Xavier Major Roca, Mojca Maticic and Astrid Leicht

    Hepatology, Medicine and Policy 2016 1:14

    Published on: 18 October 2016

  4. Research

    Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

    The human immunodeficiency virus (HIV) epidemic in Russia, driven by injection drug use, has seen a steady rise in the past two decades. Hepatitis C virus (HCV) infection is highly prevalent in people who inje...

    Judith I. Tsui, Stephen C. Ko, Evgeny Krupitsky, Dmitry Lioznov, Christine E. Chaisson, Natalia Gnatienko and Jeffrey H. Samet

    Hepatology, Medicine and Policy 2016 1:13

    Published on: 11 October 2016

  5. Debate

    Roundtable discussion: how the World Hepatitis Summit 2015 strengthened stakeholders’ efforts to combat viral hepatitis

    The inaugural World Hepatitis Summit was jointly convened by the World Health Organization (WHO) and the World Hepatitis Alliance and hosted by the Scottish Government and supported by Glasgow Caledonian Unive...

    Charles Gore, Stefan Wiktor, David Goldberg, Sharon Hutchinson, Jose Antonio Oñate Moreno and Raquel Peck

    Hepatology, Medicine and Policy 2016 1:12

    Published on: 7 October 2016

  6. Research

    Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany

    People who inject drugs (PWID) are disproportionately affected by both HIV and hepatitis C infection (HCV). Awareness of infection status is essential to ensure linkage to appropriate healthcare for those infe...

    Stine Nielsen, Martyna Gassowski, Benjamin Wenz, Norbert Bannert, Claus-Thomas Bock, Claudia Kücherer, R. Stefan Ross, Viviane Bremer, Ulrich Marcus and Ruth Zimmermann

    Hepatology, Medicine and Policy 2016 1:8

    Published on: 1 September 2016

  7. Research

    HCV/HIV coinfection among people who inject drugs and enter opioid substitution treatment in Greece: prevalence and correlates

    HCV/HIV coinfection in people who inject drugs is a public health issue, which presents a variety of challenges to healthcare providers. The determinants of HCV/HIV coinfection in this population are nonethele...

    Anastasios Fotiou, Eleftheria Kanavou, Argyro Antaraki, Clive Richardson, Manina Terzidou and Anna Kokkevi

    Hepatology, Medicine and Policy 2016 1:9

    Published on: 25 August 2016

  8. Research

    Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysis

    HIV co-infection exacerbates hepatitis C disease, increasing the risk of cirrhosis and hepatitis C-related mortality. Combination antiretroviral therapy (cART) is the current standard treatment for co-infected...

    Alexis Llewellyn, Mark Simmonds, Will L Irving, Ginny Brunton and Amanda J Sowden

    Hepatology, Medicine and Policy 2016 1:10

    Published on: 15 August 2016

  9. Research

    Knowledge about hepatitis B and hepatitis C virus infection and consequences: a cross-sectional assessment of baseline knowledge among infected patients in West Bengal, India

    India has a high burden of disease from hepatitis B virus (HBV), with 3.7 % point-prevalence, as well as from hepatitis C virus (HCV), with 1–1.5 % prevalence. Societal ignorance about HBV and HCV in India lim...

    Partha Sarathi Mukherjee, Eliza Dutta, Dipesh Kr. Das, Shatabdi Ghosh, Suvadip Neogi and Arka Sarkar

    Hepatology, Medicine and Policy 2016 2:6

    Published on: 8 August 2016

  10. Editorial

    HMAP, World Hepatitis Day and the bigger health systems picture

    World Hepatitis Day 2016 marks one year since Hepatology, Medicine and Policy (HMAP) began accepting submissions. There have been many major developments in the fight against hepatitis B virus (HBV) and hepatitis...

    Jeffrey V. Lazarus, Kelly Safreed-Harmon and Mojca Maticic

    Hepatology, Medicine and Policy 2016 2:4

    Published on: 27 July 2016

  11. Review

    National alliance for Wilson’s disease: health policy in Costa Rica

    Wilson’s disease is an inherited disorder in which defective biliary excretion of copper leads to its accumulation, particularly in the liver and brain. Mutations in the ATP7B gene on chromosome 13 cause Wilso...

    Francisco Hevia-Urrutia, Ileana Alvarado-Echeverría, Alfredo Sanabria-Castro, Marta Sánchez-Molina, Luis Meza-Sierra, Alexander Parajeles-Vindas, Oscar Méndez-Blanca, Álvaro Sánchez-Siles, Manuel Saborío-Rocafort, Marcela Barguil-Gallardo, Iliana Chavarría-Quirós and Cecilia Monge-Bonilla

    Hepatology, Medicine and Policy 2016 2:5

    Published on: 25 July 2016

  12. Review

    Urgent action to fight hepatitis C in people who inject drugs in Europe

    Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and liver cancer, is curable in most people. Injecting drug use currently accounts for 80 % of new HCV infections with a known transmissi...

    John F. Dillon, Jeffrey V. Lazarus and Homie A. Razavi

    Hepatology, Medicine and Policy 2016 1:2

    Published on: 30 June 2016

  13. Research

    Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014)

    Hepatitis B and C are major public health threats in the World Health Organization (WHO) European Region. Viral hepatitis surveillance shortcomings have resulted in many WHO Member States having insufficient d...

    Jeffrey V. Lazarus, Antons Mozalevskis, Kelly Safreed-Harmon and Irina Eramova

    Hepatology, Medicine and Policy 2016 1:3

    Published on: 30 June 2016

  14. Research

    Predisposing, enabling, and need factors associated with utilization of HCV testing services among PWID in two settings in India

    The Hepatitis C virus (HCV) is very common among people who inject drugs (PWID), yet PWID in India have suboptimal access to HCV testing and treatment. This study sought to identify HCV risk factors among male...

    Ruchi Sogarwal, Varada Madge, Pratyush Bishi, Apam Woleng and Rishi Garg

    Hepatology, Medicine and Policy 2016 1:1

    Published on: 29 June 2016

  15. Research

    A community- based hepatitis B linkage-to-care program: a case study on Asian Americans chronically infected with hepatitis B virus

    Hepatitis B is an important disease of ethnic disparity which affects Asian Americans and other minority populations disproportionately. Despite the high prevalence of hepatitis B in Asian Americans, many of t...

    Chul S. Hyun, William R. Ventura, Soon S. Kim, Soyoung Yoon and Seulgi Lee

    Hepatology, Medicine and Policy 2016 1:6

    Published on: 5 May 2016

  16. Research

    Coverage of different health insurance programs and medical costs associated with chronic hepatitis C infection in mainland China: a cross-sectional survey in 20 provinces

    Hepatitis C virus (HCV) imposes a considerable disease burden in China, with at least 10 million people chronically infected. Little is known about the financial impact of the HCV epidemic, nor about the exten...

    Hai-yang Zhou, Shuang Liu, Su-jun Zheng, Xiao-xia Peng, Yu Chen, Carol Duan, Qing-fen Zheng, Zhao Wang and Zhong-ping Duan

    Hepatology, Medicine and Policy 2016 1:7

    Published on: 28 April 2016

  17. Research

    Hepatitis B knowledge among key stakeholders in Haimen City, China: Implications for addressing chronic HBV infection

    This article describes hepatitis B-related knowledge, attitudes and practices after completion of the Gateway to Care campaign, a citywide public health education program that targeted city residents, health c...

    Chari Cohen, Alison A. Evans, Peixin Huang, W. Thomas London, Joan M. Block and Gang Chen

    Hepatology, Medicine and Policy 2016 1:4

    Published on: 14 April 2016

  18. Research

    A new paradigm evaluating cost per cure of HCV infection in the UK

    New interferon (IFN)-free treatments for hepatitis C are more effective, safer but more expensive than current IFN-based therapies. Comparative data of these, versus current first generation protease inhibitor...

    Stephen T. Barclay, Graham S. Cooke, Elizabeth Holtham, Aline Gauthier, Jeremie Schwarzbard, Petar Atanasov and William L. Irving

    Hepatology, Medicine and Policy 2016 1:2

    Published on: 14 April 2016

  19. Research

    State of viral hepatitis knowledge and testing uptake in Brazil: Findings from the National Survey of Knowledge, Attitudes and Practices (PCAP-2013)

    Data were obtained from the third National Survey of Knowledge, Attitudes and Practices of HIV and other Sexually Transmitted Infections (STI) (PCAP-2013) and used to describe the current state of viral hepati...

    Silvano Barbosa de Oliveira, Meritxell Sabidó, Ana Roberta Pati Pascom, Juliana Machado Gisiviez, Adele Schwartz Benzaken and Fábio Mesquita

    Hepatology, Medicine and Policy 2016 1:3

    Published on: 14 April 2016

Previous Page Page 1 of 1 Next Page